Literature DB >> 21495179

Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: a review.

Marni E Axelrad1, David D Schwartz, Jennifer M Katzenstein, Elizabeth Hopkins, Karen W Gripp.   

Abstract

Costello syndrome is a rare rasopathy resulting from germline mutations of the proto-oncogene HRAS. Its phenotype includes severe failure-to-thrive, cardiac abnormalities, a predisposition to benign and malignant tumors, hypotonia, and developmental delay. Costello syndrome is associated with cognitive impairment, including intellectual functioning generally in the mild to moderate range of disability, commensurate adaptive functioning, and increased anxiety. Relative strengths have been found for nonverbal fluid reasoning (FR). Gender effects have been reported, with females showing better adaptive functioning across domains. Developmentally, nonverbal skills plateau in late childhood/early adolescence, whereas the rate of vocabulary acquisition may increase in adolescence into early adulthood. Here we review the literature assessing cognitive, adaptive, and behavioral functioning in Costello syndrome, and we provide data from an ongoing longitudinal study. Severity of cognitive impairment may depend upon the specific HRAS mutation, as three individuals with the p.G13C change showed average nonverbal FR skills and borderline-to-low average overall nonverbal IQ. Further, separation anxiety is more common in Costello syndrome than in the general population, affecting 39% of this cohort, and males are more often overly anxious than females. Interrelations between anxiety and cognitive and adaptive functioning were found, pointing to functional difficulties as a likely source of stress and anxiety. Taking into account data from animal models, cognitive and behavioral changes likely originate from abnormal differentiation of neuronal precursor cells, which result in structural and functional brain differences. 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21495179     DOI: 10.1002/ajmg.c.30299

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  16 in total

1.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

Review 2.  Genetic contribution to neurodevelopmental outcomes in congenital heart disease: are some patients predetermined to have developmental delay?

Authors:  Caitlin K Rollins; Jane W Newburger; Amy E Roberts
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

3.  RASopathies are associated with a distinct personality profile.

Authors:  Varoona Bizaoui; Jessica Gage; Rita Brar; Katherine A Rauen; Lauren A Weiss
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-04-16       Impact factor: 3.568

4.  Age-related differences in prevalence of autism spectrum disorder symptoms in children and adolescents with Costello syndrome.

Authors:  David D Schwartz; Jennifer M Katzenstein; Eric J Highley; Deborah L Stabley; Katia Sol-Church; Karen W Gripp; Marni E Axelrad
Journal:  Am J Med Genet A       Date:  2017-04-04       Impact factor: 2.802

Review 5.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

6.  Autism traits in the RASopathies.

Authors:  Brigid Adviento; Iris L Corbin; Felicia Widjaja; Guillaume Desachy; Nicole Enrique; Tena Rosser; Susan Risi; Elysa J Marco; Robert L Hendren; Carrie E Bearden; Katherine A Rauen; Lauren A Weiss
Journal:  J Med Genet       Date:  2013-10-07       Impact factor: 6.318

7.  Verbal memory functioning in adolescents and young adults with Costello syndrome: evidence for relative preservation in recognition memory.

Authors:  David D Schwartz; Jennifer M Katzenstein; Elisabeth Hopkins; Deborah L Stabley; Katia Sol-Church; Karen W Gripp; Marni E Axelrad
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

8.  In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.

Authors:  Tiantian Wang; Laura de Kok; Rob Willemsen; Ype Elgersma; J Gerard G Borst
Journal:  Front Cell Neurosci       Date:  2015-07-03       Impact factor: 5.505

9.  Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models.

Authors:  Jadwiga Schreiber; Laura-Anne Grimbergen; Iris Overwater; Thijs van der Vaart; Jeffrey Stedehouder; Alberto J Schuhmacher; Carmen Guerra; Steven A Kushner; Dick Jaarsma; Ype Elgersma
Journal:  Sci Rep       Date:  2017-04-28       Impact factor: 4.379

10.  MEK Inhibitors Reverse cAMP-Mediated Anxiety in Zebrafish.

Authors:  Pia R Lundegaard; Corina Anastasaki; Nicola J Grant; Rowland R Sillito; Judith Zich; Zhiqiang Zeng; Karthika Paranthaman; Anders Peter Larsen; J Douglas Armstrong; David J Porteous; E Elizabeth Patton
Journal:  Chem Biol       Date:  2015-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.